Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Friday, June 2, 2017

Gene therapy could offer life-long protection from severe allergies stat : firstnewspaper24

A new study carried out by researchers in Australia and published in JCI Insight has paved way for life-long protection from severe allergies through gene therapy. These cells then produced new blood cells that express the protein and target specific immune cells, 'turning off' the allergic response. The team's eventual goal is to create a single injected gene therapy that will replace short-term treatments that target allergy symptoms with varying degrees of effectiveness. The team also added that their priority could be to target those individuals that have severe asthma or potentially lethal food allergies. One of the reasons why treatments don't work is that the immune cells, known as T-cells, develop a form of immune 'memory' and become very resistant to treatments.



Gene therapy could offer life-long protection from severe allergies
Tennessee Whiskey singer Chris will now be undergoing physical therapy in a bid to help his hand heal following the injury. Country singer Chris Stapleton has revealed he postponed his tour because of an injury which left him with a broken bone and detached tendon in his right hand. The hand injury comes after Chris was forced to postpone a concert in California last year due to vocal issues. However, in a letter written to his fans and posted on his website on Thursday, Chris explained that a severe injury has affected his ability to play guitar. "The doctor is hopeful that with some physical therapy I will be playing guitar again soon," he continued.

Gene therapy could 'turn off' severe allergies


Chris Stapleton undergoing physical therapy after severe hand injury
"At the moment, the target population might be those individuals who have severe asthma or potentially lethal food allergies." Dr Steptoe said the eventual goal would be a single injected gene therapy, replacing short-term treatments that target allergy symptoms with varying degrees of effectiveness. Media please note: A broadcast quality interview with Dr Steptoe and footage of his team working in the laboratory is available on request. "Those engineered cells produce new blood cells that express the protein and target specific immune cells, 'turning off' the allergic response." "The challenge in asthma and allergies is that these immune cells, known as T-cells, develop a form of immune 'memory' and become very resistant to treatments.


collected by :Lucy William

To follow all the new news about Health care

No comments:

Post a Comment